California Drug Injury Lawyers Examine Risks With Cardiac Nuclear Stress Test Medications
December 2nd, 2013| California Drug Injury Lawyers with Berg Injury Lawyers explain researchers have discovered a risk of heart attack and death when using the medications Lexiscan (regadenoson) and Adenoscan (adenosine). A press release from the U.S. Food and Drug Administration (FDA) states the drugs are used in cardiac nuclear stress tests for patients who are unable to exercise. The medications can help doctors and medical staff to identify symptoms of coronary artery disease in these individuals. The drugs work by increasing blood flow to identify blockages and the blood typically flows to healthier areas of the body. However, researchers have stated the increased blood flow can also lead to a risk of the patient suffering a heart attack, and potentially, death. In response to the problems, the FDA is planning to update the warning labels on the products. Furthermore, the agency is stating that resuscitation equipment and trained staff be on hand when and if the drugs are administered to a patient. Berg Injury Lawyers and their team of California Personal Injury Lawyers recognize the dangers certain medications can pose to users. That is why the firm urges patients to read all warning labels on a medication and discuss any questions with your physician prior to beginning a regimen of medication.